#USA #Senior Notes #Birmingham #Encompass Health #NYSE EHC

Encompass Health's New Senior Notes Offering

On August 10, 2026, Encompass Health Corp. (NYSE: EHC) disclosed its pricing for a private offering of an additional $100 million in 5.875% senior notes due in 2034, effectively expanding their recent bond issuance. This action is part of the company’s ongoing strategy to strengthen its financial foundation and manage existing debt obligations more effectively.

Details of the Offering

The newly offered senior notes will be sold at a price of 98.75% of their principal amount and are essentially a reopening of the company’s original senior notes issued earlier in May 2026. This means they will be treated as part of the same class as the existing notes, ensuring consistency in terms and conditions excluding the issuance date and pricing.

Interest payments on these additional notes will occur semiannually, starting on December 1, 2026. Such a structured payout provides a clear timeline for investors to plan their cash flows while supporting Encompass Health in maintaining liquidity.

The offering is anticipated to close on August 13, 2026, pending customary closing conditions. By utilizing the funds raised, along with existing cash reserves, Encompass Health intends to repay existing amounts under its senior secured revolving credit facility. This move not only reflects prudent fiscal management but also positions the company for sustained growth in the rehabilitation healthcare sector.

Who Can Invest?

The additional notes are available exclusively in the United States to individuals deemed qualified institutional buyers as per Rule 144A under the Securities Act of 1933. Selected international investors can also participate as part of certain non-U.S. engagements under Regulation S, which allows offshore transactions to take place.

The announcement underlines that this private offering and its guarantees have not been registered under the Securities Act or any related state securities laws. Consequently, the additional notes cannot be offered or sold within the United States without proper registration or exemption.

About Encompass Health

Encompass Health Corp., headquartered in Birmingham, Alabama, is recognized as the nation’s largest operator of inpatient rehabilitation hospitals. With a network consisting of 176 hospitals across 39 states and Puerto Rico, the company delivers high-quality rehabilitative care to patients recovering from significant injuries or illnesses. They are noted for their advanced technology and innovative treatment approaches that promote optimal recovery. Encompass Health has received accolades from reputable organizations such as Newsweek, Forbes, and Becker's Healthcare, marking it one of America's leading healthcare employers.

In a rapidly evolving healthcare landscape, these financial maneuvers not only signify Encompass Health's commitment to enhancing its operational efficiency but also its capacity to adapt and thrive amidst market challenges. By propping up liquidity through such offerings, the company positions itself strongly against potential economic disruptions while aiming to continue its mission of rehabilitating patients back to health.

This strategic financial management is vital, especially considering the unpredictable nature of the healthcare environment and capital markets. Encompass Health's proactive steps provide reassurance to its stakeholders about its sustainability and reliability as a prime healthcare provider.

In conclusion, as Encompass Health moves forward with its plans, its decision to expand its senior notes offering highlights a significant step in reinforcing its financial health, ensuring continued focus on delivering quality care, and remaining a key player in the rehabilitation sector.